French biotech firms Nanobiotix and Innate Pharma await catalysts

Nanobiotix and Innate Pharma, two small French biotech caps, attract speculative stock market attention in June 2026.

Published 9sem1 sourceMajorupdated 3sem

≈ 23sSpeed

The fact

Nanobiotix tests the 30-euro level while Innate Pharma sees rumors emerge of strategic interest from large groups like Sanofi.

Investors speculate on possible stock reversals or restructuring in the healthcare sector.

Click the link to read an article on the topic:

Explore this topic

Jun 5French biotech firms Nanobiotix and Innate Pharma await catalyststhis article

Auto-synthesis from 1 media source · identified on June 5, 2026